Search

Your search keyword '"Campath (Medication) -- Evaluation -- Product/service Evaluations"' showing total 2 results
Start Over Descriptor "Campath (Medication) -- Evaluation -- Product/service Evaluations" Topic health care industry

Refine your results

2 results on '"Campath (Medication) -- Evaluation -- Product/service Evaluations"'

1. Study reports success in treating refractory B-CLL, T-PLL

Subjects
Chronic lymphocytic leukemia -- Drug therapy, Business, Health, Health care industry, Campath (Medication) -- Evaluation -- Product/service Evaluations
Abstract

2003 JAN 14 - (NewsRx.com & NewsRx.net) -- Findings obtained from a compassionate use study of the humanized monoclonal antibody alemtuzumab (Campath/MabCampath) in patients with refractory B-cell chronic lymphocytic leukemia [...]

Published
2003

2. Combination of alemtuzumab, fludarabine phosphate effective, safe

Subjects
Chronic lymphocytic leukemia -- Drug therapy, Business, Health, Health care industry, Campath (Medication) -- Evaluation -- Product/service Evaluations, Fludara (Medication) -- Evaluation -- Product/service Evaluations
Abstract

2003 JAN 14 - (NewsRx.com & NewsRx.net) -- Efficacy and safety data from an ongoing phase II clinical trial of combination fludarabine phosphate (Fludara) and alemtuzumab (Campath/MabCampath) therapy (FluCam) for [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results